Synairgen Research Ltd.
Quick facts
Phase 3 pipeline
- SNG001 · Respiratory
SNG001 is an inhaled interferon beta-1a, which works by stimulating the body's immune response to fight off respiratory viruses.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: